🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareHas anyone dealt with pharmacogenomics of glp-1 response? Page 2

Has anyone dealt with pharmacogenomics of glp-1 response?

LarryQC_SD Wed, Jul 30, 2025 at 5:56 AM 7 replies 1,337 viewsPage 2 of 2
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Jul 30, 2025 at 1:30 PM#6
TrialTracker_MD said:
The gap between trial results and real-world results is consistent and it is not fraud.

This is where I part company with the consensus forming above. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: Jul 30, 2025 at 4:30 PM
37 7Dr.LeslieOBGYN, MikeNYC_runner and 34 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Jul 30, 2025 at 4:29 PM#7
LarryQC_SD said:
My own curve sits about four points below the published mean and I spent two months assuming that meant something was wrong with me or with my…

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.75 (95% CI 0.68-0.85), I²=33%. This is a robust and consistent effect.

36 6laura_annarbor, JenMemphis, pat_auckland and 33 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jul 30, 2025 at 7:29 PM#8
PurityPaulOR said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

Last edited: Jul 30, 2025 at 8:29 PM
35 5AttorneyGrant, DebRD_ATL, KristenIndy and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Jul 30, 2025 at 10:29 PM#9

One thing that is still open after PedsEndoPhilly’s answer:

What did you change at the same time, and can you separate the two now?

34 4PharmHunterJen, TomTeleRx, DoseLogDan and 31 others
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Jul 31, 2025 at 12:52 PM#10

OP back with an update, since a thread like this is useless without one.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

Last edited: Jul 31, 2025 at 1:52 PM
24 24dan_philly, MeganSA_TX, LarryQC_SD and 21 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register